薬用炭素 - 世界市場シェアとランキング、全体売上高と需要予測 2024-2030Medicinal Carbon - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030 米国薬局方(USP)で定義されているように、活性炭とは、様々な有機物を破壊蒸留した残渣を吸着力を高めるために処理したものである。メディシナルカーボンは、高純度、強力な吸着力、速い吸着速度を持つ医療用特... もっと見る
※当ページの内容はウェブ更新時の情報です。
サマリー米国薬局方(USP)で定義されているように、活性炭とは、様々な有機物を破壊蒸留した残渣を吸着力を高めるために処理したものである。メディシナルカーボンは、高純度、強力な吸着力、速い吸着速度を持つ医療用特殊材料であり、過去100年間、中毒患者の治療に広く使用されてきた。2023年の薬用炭素の世界市場規模は100万米ドルと推定され、2024-2030年の予測期間中の年平均成長率は%で、2030年には100万米ドルに再調整されると予測されている。 世界の医薬品市場は2022年に1,475億米ドルで、今後6年間のCAGRは5%で成長する。医薬品市場には、化学医薬品と生物学的製剤が含まれる。生物製剤は2022年に3810億米ドルになると予想されている。これに対し、化学医薬品市場は2018年の1,050億米ドルから2022年には1,090億米ドルに増加すると推定されている。医薬品市場の要因としては、医療需要の増加、技術の進歩、慢性疾患の有病率の上昇、医薬品製造分野の開発に対する民間&政府機関からの資金提供の増加、医薬品の研究開発活動の活発化などが挙げられる。しかし、厳しい規制、研究開発費の高騰、特許切れといった課題にも直面している。企業は、市場での競争力を維持し、必要としている患者に確実に製品を届けるために、継続的に技術革新を行い、こうした課題に適応していく必要がある。さらに、COVID-19の流行はワクチン開発とサプライチェーン・マネジメントの重要性を浮き彫りにし、製薬企業が新たな公衆衛生のニーズに機敏に対応する必要性をさらに強調している。 レポートの範囲 本レポートは、薬用炭素の世界市場について、地域別・国別、タイプ別、用途別の分析とともに、総販売量、販売収益、価格、主要企業の市場シェア、ランキングに焦点を当て、包括的に紹介することを目的としています。 薬用炭素の市場規模、推計、予測は、2023年を基準年とし、2019年から2030年までの期間の履歴データと予測データを加えた販売量(トン)と販売収益(百万ドル)で提供されます。定量的、定性的な分析により、読者がビジネス/成長戦略を策定し、市場競争状況を評価し、現在の市場における自社のポジションを分析し、薬用炭素に関する情報に基づいたビジネス上の意思決定を行うのに役立ちます。 市場区分 企業別 ノーリット エコフレンドカーボン エミス・ヴィト クラレ バーネビー・チェニー デュポン ドルダー アトラスカーボン カルゴン・カーボン・コーポレーション ウィトコ・ケミカル・コーポレーション インジェビティ 大阪ガス株式会社 ヘイカーブPLC タイプ別セグメント 化学的活性化 物理的活性化 用途別セグメント 透析/血液洗浄 人工肛門 創傷の臭い除去 医薬品の脱色 緊急毒物解毒剤 地域別 北米 米国 カナダ ヨーロッパ ドイツ フランス 英国 イタリア ロシア アジア太平洋 中国 日本 韓国 中国 台湾 東南アジア インド ラテンアメリカ メキシコ ブラジル アルゼンチン 中東・アフリカ トルコ サウジアラビア アラブ首長国連邦 各章の概要 第1章: レポートの対象範囲、世界の総市場規模(バルブ、数量、価格)を紹介。本章ではまた、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界のメーカーが直面する課題とリスク、業界の関連政策の分析を提供します。 第2章 薬用炭素メーカーの競争環境、価格、売上高、市場シェア、最新の開発計画、合併・買収情報などを詳細に分析。 第3章:タイプ別の様々な市場セグメントの分析を提供し、各市場セグメントの市場規模と発展の可能性をカバーし、読者が異なる市場セグメントのブルーオーシャン市場を見つけるのに役立ちます。 第4章:アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの市場規模と発展可能性をカバーし、読者が異なる川下市場のブルーオーシャン市場を見つけるのに役立ちます。 第5章:地域レベルでの薬用炭素の販売、収益。各地域の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、将来発展見込み、市場空間、市場規模を紹介する。 第6章 薬用炭素の国別販売、収益。各国・地域のタイプ別、用途別のシグメイトデータを提供。 第7章:主要企業のプロファイルを提供し、製品の売上高、収益、価格、売上総利益率、製品紹介、最近の開発など、市場の主要企業の基本的な状況を詳細に紹介します。 第8章:産業の上流と下流を含む産業チェーンの分析。 第9章:結論 目次1 Market Overview1.1 Medicinal Carbon Product Introduction 1.2 Global Medicinal Carbon Market Size Forecast 1.2.1 Global Medicinal Carbon Sales Value (2019-2030) 1.2.2 Global Medicinal Carbon Sales Volume (2019-2030) 1.2.3 Global Medicinal Carbon Sales Price (2019-2030) 1.3 Medicinal Carbon Market Trends & Drivers 1.3.1 Medicinal Carbon Industry Trends 1.3.2 Medicinal Carbon Market Drivers & Opportunity 1.3.3 Medicinal Carbon Market Challenges 1.3.4 Medicinal Carbon Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Medicinal Carbon Players Revenue Ranking (2023) 2.2 Global Medicinal Carbon Revenue by Company (2019-2024) 2.3 Global Medicinal Carbon Players Sales Volume Ranking (2023) 2.4 Global Medicinal Carbon Sales Volume by Company Players (2019-2024) 2.5 Global Medicinal Carbon Average Price by Company (2019-2024) 2.6 Key Manufacturers Medicinal Carbon Manufacturing Base Distribution and Headquarters 2.7 Key Manufacturers Medicinal Carbon Product Offered 2.8 Key Manufacturers Time to Begin Mass Production of Medicinal Carbon 2.9 Medicinal Carbon Market Competitive Analysis 2.9.1 Medicinal Carbon Market Concentration Rate (2019-2024) 2.9.2 Global 5 and 10 Largest Manufacturers by Medicinal Carbon Revenue in 2023 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medicinal Carbon as of 2023) 2.10 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Chemical Activation 3.1.2 Physical Activation 3.2 Global Medicinal Carbon Sales Value by Type 3.2.1 Global Medicinal Carbon Sales Value by Type (2019 VS 2023 VS 2030) 3.2.2 Global Medicinal Carbon Sales Value, by Type (2019-2030) 3.2.3 Global Medicinal Carbon Sales Value, by Type (%) (2019-2030) 3.3 Global Medicinal Carbon Sales Volume by Type 3.3.1 Global Medicinal Carbon Sales Volume by Type (2019 VS 2023 VS 2030) 3.3.2 Global Medicinal Carbon Sales Volume, by Type (2019-2030) 3.3.3 Global Medicinal Carbon Sales Volume, by Type (%) (2019-2030) 3.4 Global Medicinal Carbon Average Price by Type (2019-2030) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Dialysis/Blood Cleaning 4.1.2 Ostomy 4.1.3 Wound Odour Removal 4.1.4 Decolourisation of Pharmaceuticals 4.1.5 Emergency Poison Antidote 4.2 Global Medicinal Carbon Sales Value by Application 4.2.1 Global Medicinal Carbon Sales Value by Application (2019 VS 2023 VS 2030) 4.2.2 Global Medicinal Carbon Sales Value, by Application (2019-2030) 4.2.3 Global Medicinal Carbon Sales Value, by Application (%) (2019-2030) 4.3 Global Medicinal Carbon Sales Volume by Application 4.3.1 Global Medicinal Carbon Sales Volume by Application (2019 VS 2023 VS 2030) 4.3.2 Global Medicinal Carbon Sales Volume, by Application (2019-2030) 4.3.3 Global Medicinal Carbon Sales Volume, by Application (%) (2019-2030) 4.4 Global Medicinal Carbon Average Price by Application (2019-2030) 5 Segmentation by Region 5.1 Global Medicinal Carbon Sales Value by Region 5.1.1 Global Medicinal Carbon Sales Value by Region: 2019 VS 2023 VS 2030 5.1.2 Global Medicinal Carbon Sales Value by Region (2019-2024) 5.1.3 Global Medicinal Carbon Sales Value by Region (2025-2030) 5.1.4 Global Medicinal Carbon Sales Value by Region (%), (2019-2030) 5.2 Global Medicinal Carbon Sales Volume by Region 5.2.1 Global Medicinal Carbon Sales Volume by Region: 2019 VS 2023 VS 2030 5.2.2 Global Medicinal Carbon Sales Volume by Region (2019-2024) 5.2.3 Global Medicinal Carbon Sales Volume by Region (2025-2030) 5.2.4 Global Medicinal Carbon Sales Volume by Region (%), (2019-2030) 5.3 Global Medicinal Carbon Average Price by Region (2019-2030) 5.4 North America 5.4.1 North America Medicinal Carbon Sales Value, 2019-2030 5.4.2 North America Medicinal Carbon Sales Value by Country (%), 2023 VS 2030 5.5 Europe 5.5.1 Europe Medicinal Carbon Sales Value, 2019-2030 5.5.2 Europe Medicinal Carbon Sales Value by Country (%), 2023 VS 2030 5.6 Asia Pacific 5.6.1 Asia Pacific Medicinal Carbon Sales Value, 2019-2030 5.6.2 Asia Pacific Medicinal Carbon Sales Value by Country (%), 2023 VS 2030 5.7 South America 5.7.1 South America Medicinal Carbon Sales Value, 2019-2030 5.7.2 South America Medicinal Carbon Sales Value by Country (%), 2023 VS 2030 5.8 Middle East & Africa 5.8.1 Middle East & Africa Medicinal Carbon Sales Value, 2019-2030 5.8.2 Middle East & Africa Medicinal Carbon Sales Value by Country (%), 2023 VS 2030 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Medicinal Carbon Sales Value Growth Trends, 2019 VS 2023 VS 2030 6.2 Key Countries/Regions Medicinal Carbon Sales Value 6.2.1 Key Countries/Regions Medicinal Carbon Sales Value, 2019-2030 6.2.2 Key Countries/Regions Medicinal Carbon Sales Volume, 2019-2030 6.3 United States 6.3.1 United States Medicinal Carbon Sales Value, 2019-2030 6.3.2 United States Medicinal Carbon Sales Value by Type (%), 2023 VS 2030 6.3.3 United States Medicinal Carbon Sales Value by Application, 2023 VS 2030 6.4 Europe 6.4.1 Europe Medicinal Carbon Sales Value, 2019-2030 6.4.2 Europe Medicinal Carbon Sales Value by Type (%), 2023 VS 2030 6.4.3 Europe Medicinal Carbon Sales Value by Application, 2023 VS 2030 6.5 China 6.5.1 China Medicinal Carbon Sales Value, 2019-2030 6.5.2 China Medicinal Carbon Sales Value by Type (%), 2023 VS 2030 6.5.3 China Medicinal Carbon Sales Value by Application, 2023 VS 2030 6.6 Japan 6.6.1 Japan Medicinal Carbon Sales Value, 2019-2030 6.6.2 Japan Medicinal Carbon Sales Value by Type (%), 2023 VS 2030 6.6.3 Japan Medicinal Carbon Sales Value by Application, 2023 VS 2030 6.7 South Korea 6.7.1 South Korea Medicinal Carbon Sales Value, 2019-2030 6.7.2 South Korea Medicinal Carbon Sales Value by Type (%), 2023 VS 2030 6.7.3 South Korea Medicinal Carbon Sales Value by Application, 2023 VS 2030 6.8 Southeast Asia 6.8.1 Southeast Asia Medicinal Carbon Sales Value, 2019-2030 6.8.2 Southeast Asia Medicinal Carbon Sales Value by Type (%), 2023 VS 2030 6.8.3 Southeast Asia Medicinal Carbon Sales Value by Application, 2023 VS 2030 6.9 India 6.9.1 India Medicinal Carbon Sales Value, 2019-2030 6.9.2 India Medicinal Carbon Sales Value by Type (%), 2023 VS 2030 6.9.3 India Medicinal Carbon Sales Value by Application, 2023 VS 2030 7 Company Profiles 7.1 NORIT 7.1.1 NORIT Company Information 7.1.2 NORIT Introduction and Business Overview 7.1.3 NORIT Medicinal Carbon Sales, Revenue and Gross Margin (2019-2024) 7.1.4 NORIT Medicinal Carbon Product Offerings 7.1.5 NORIT Recent Development 7.2 EcoFriend Carbon 7.2.1 EcoFriend Carbon Company Information 7.2.2 EcoFriend Carbon Introduction and Business Overview 7.2.3 EcoFriend Carbon Medicinal Carbon Sales, Revenue and Gross Margin (2019-2024) 7.2.4 EcoFriend Carbon Medicinal Carbon Product Offerings 7.2.5 EcoFriend Carbon Recent Development 7.3 Emis Vito 7.3.1 Emis Vito Company Information 7.3.2 Emis Vito Introduction and Business Overview 7.3.3 Emis Vito Medicinal Carbon Sales, Revenue and Gross Margin (2019-2024) 7.3.4 Emis Vito Medicinal Carbon Product Offerings 7.3.5 Emis Vito Recent Development 7.4 Kuraray 7.4.1 Kuraray Company Information 7.4.2 Kuraray Introduction and Business Overview 7.4.3 Kuraray Medicinal Carbon Sales, Revenue and Gross Margin (2019-2024) 7.4.4 Kuraray Medicinal Carbon Product Offerings 7.4.5 Kuraray Recent Development 7.5 Barnebey Cheney 7.5.1 Barnebey Cheney Company Information 7.5.2 Barnebey Cheney Introduction and Business Overview 7.5.3 Barnebey Cheney Medicinal Carbon Sales, Revenue and Gross Margin (2019-2024) 7.5.4 Barnebey Cheney Medicinal Carbon Product Offerings 7.5.5 Barnebey Cheney Recent Development 7.6 Dupont 7.6.1 Dupont Company Information 7.6.2 Dupont Introduction and Business Overview 7.6.3 Dupont Medicinal Carbon Sales, Revenue and Gross Margin (2019-2024) 7.6.4 Dupont Medicinal Carbon Product Offerings 7.6.5 Dupont Recent Development 7.7 Dolder 7.7.1 Dolder Company Information 7.7.2 Dolder Introduction and Business Overview 7.7.3 Dolder Medicinal Carbon Sales, Revenue and Gross Margin (2019-2024) 7.7.4 Dolder Medicinal Carbon Product Offerings 7.7.5 Dolder Recent Development 7.8 Atlas Carbon 7.8.1 Atlas Carbon Company Information 7.8.2 Atlas Carbon Introduction and Business Overview 7.8.3 Atlas Carbon Medicinal Carbon Sales, Revenue and Gross Margin (2019-2024) 7.8.4 Atlas Carbon Medicinal Carbon Product Offerings 7.8.5 Atlas Carbon Recent Development 7.9 Calgon Carbon Corporation 7.9.1 Calgon Carbon Corporation Company Information 7.9.2 Calgon Carbon Corporation Introduction and Business Overview 7.9.3 Calgon Carbon Corporation Medicinal Carbon Sales, Revenue and Gross Margin (2019-2024) 7.9.4 Calgon Carbon Corporation Medicinal Carbon Product Offerings 7.9.5 Calgon Carbon Corporation Recent Development 7.10 Witco Chemical Corporation 7.10.1 Witco Chemical Corporation Company Information 7.10.2 Witco Chemical Corporation Introduction and Business Overview 7.10.3 Witco Chemical Corporation Medicinal Carbon Sales, Revenue and Gross Margin (2019-2024) 7.10.4 Witco Chemical Corporation Medicinal Carbon Product Offerings 7.10.5 Witco Chemical Corporation Recent Development 7.11 Ingevity 7.11.1 Ingevity Company Information 7.11.2 Ingevity Introduction and Business Overview 7.11.3 Ingevity Medicinal Carbon Sales, Revenue and Gross Margin (2019-2024) 7.11.4 Ingevity Medicinal Carbon Product Offerings 7.11.5 Ingevity Recent Development 7.12 Osaka Gas Co.,Ltd. 7.12.1 Osaka Gas Co.,Ltd. Company Information 7.12.2 Osaka Gas Co.,Ltd. Introduction and Business Overview 7.12.3 Osaka Gas Co.,Ltd. Medicinal Carbon Sales, Revenue and Gross Margin (2019-2024) 7.12.4 Osaka Gas Co.,Ltd. Medicinal Carbon Product Offerings 7.12.5 Osaka Gas Co.,Ltd. Recent Development 7.13 Haycarb PLC 7.13.1 Haycarb PLC Company Information 7.13.2 Haycarb PLC Introduction and Business Overview 7.13.3 Haycarb PLC Medicinal Carbon Sales, Revenue and Gross Margin (2019-2024) 7.13.4 Haycarb PLC Medicinal Carbon Product Offerings 7.13.5 Haycarb PLC Recent Development 8 Industry Chain Analysis 8.1 Medicinal Carbon Industrial Chain 8.2 Medicinal Carbon Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Medicinal Carbon Sales Model 8.5.2 Sales Channel 8.5.3 Medicinal Carbon Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer
SummaryAs defined by the United States Pharmacopeia (USP), activated carbon is the residue that results from the destructive distillation of various organic materials that has been treated to increase its adsorptive power. Medicinal carbon, a special medically used material with high purity, strong adsorption capacity and fast adsorption velocity, has been used extensively for the last 100 years to treat victims of poisoning. Table of Contents1 Market Overview1.1 Medicinal Carbon Product Introduction 1.2 Global Medicinal Carbon Market Size Forecast 1.2.1 Global Medicinal Carbon Sales Value (2019-2030) 1.2.2 Global Medicinal Carbon Sales Volume (2019-2030) 1.2.3 Global Medicinal Carbon Sales Price (2019-2030) 1.3 Medicinal Carbon Market Trends & Drivers 1.3.1 Medicinal Carbon Industry Trends 1.3.2 Medicinal Carbon Market Drivers & Opportunity 1.3.3 Medicinal Carbon Market Challenges 1.3.4 Medicinal Carbon Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Medicinal Carbon Players Revenue Ranking (2023) 2.2 Global Medicinal Carbon Revenue by Company (2019-2024) 2.3 Global Medicinal Carbon Players Sales Volume Ranking (2023) 2.4 Global Medicinal Carbon Sales Volume by Company Players (2019-2024) 2.5 Global Medicinal Carbon Average Price by Company (2019-2024) 2.6 Key Manufacturers Medicinal Carbon Manufacturing Base Distribution and Headquarters 2.7 Key Manufacturers Medicinal Carbon Product Offered 2.8 Key Manufacturers Time to Begin Mass Production of Medicinal Carbon 2.9 Medicinal Carbon Market Competitive Analysis 2.9.1 Medicinal Carbon Market Concentration Rate (2019-2024) 2.9.2 Global 5 and 10 Largest Manufacturers by Medicinal Carbon Revenue in 2023 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medicinal Carbon as of 2023) 2.10 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Chemical Activation 3.1.2 Physical Activation 3.2 Global Medicinal Carbon Sales Value by Type 3.2.1 Global Medicinal Carbon Sales Value by Type (2019 VS 2023 VS 2030) 3.2.2 Global Medicinal Carbon Sales Value, by Type (2019-2030) 3.2.3 Global Medicinal Carbon Sales Value, by Type (%) (2019-2030) 3.3 Global Medicinal Carbon Sales Volume by Type 3.3.1 Global Medicinal Carbon Sales Volume by Type (2019 VS 2023 VS 2030) 3.3.2 Global Medicinal Carbon Sales Volume, by Type (2019-2030) 3.3.3 Global Medicinal Carbon Sales Volume, by Type (%) (2019-2030) 3.4 Global Medicinal Carbon Average Price by Type (2019-2030) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Dialysis/Blood Cleaning 4.1.2 Ostomy 4.1.3 Wound Odour Removal 4.1.4 Decolourisation of Pharmaceuticals 4.1.5 Emergency Poison Antidote 4.2 Global Medicinal Carbon Sales Value by Application 4.2.1 Global Medicinal Carbon Sales Value by Application (2019 VS 2023 VS 2030) 4.2.2 Global Medicinal Carbon Sales Value, by Application (2019-2030) 4.2.3 Global Medicinal Carbon Sales Value, by Application (%) (2019-2030) 4.3 Global Medicinal Carbon Sales Volume by Application 4.3.1 Global Medicinal Carbon Sales Volume by Application (2019 VS 2023 VS 2030) 4.3.2 Global Medicinal Carbon Sales Volume, by Application (2019-2030) 4.3.3 Global Medicinal Carbon Sales Volume, by Application (%) (2019-2030) 4.4 Global Medicinal Carbon Average Price by Application (2019-2030) 5 Segmentation by Region 5.1 Global Medicinal Carbon Sales Value by Region 5.1.1 Global Medicinal Carbon Sales Value by Region: 2019 VS 2023 VS 2030 5.1.2 Global Medicinal Carbon Sales Value by Region (2019-2024) 5.1.3 Global Medicinal Carbon Sales Value by Region (2025-2030) 5.1.4 Global Medicinal Carbon Sales Value by Region (%), (2019-2030) 5.2 Global Medicinal Carbon Sales Volume by Region 5.2.1 Global Medicinal Carbon Sales Volume by Region: 2019 VS 2023 VS 2030 5.2.2 Global Medicinal Carbon Sales Volume by Region (2019-2024) 5.2.3 Global Medicinal Carbon Sales Volume by Region (2025-2030) 5.2.4 Global Medicinal Carbon Sales Volume by Region (%), (2019-2030) 5.3 Global Medicinal Carbon Average Price by Region (2019-2030) 5.4 North America 5.4.1 North America Medicinal Carbon Sales Value, 2019-2030 5.4.2 North America Medicinal Carbon Sales Value by Country (%), 2023 VS 2030 5.5 Europe 5.5.1 Europe Medicinal Carbon Sales Value, 2019-2030 5.5.2 Europe Medicinal Carbon Sales Value by Country (%), 2023 VS 2030 5.6 Asia Pacific 5.6.1 Asia Pacific Medicinal Carbon Sales Value, 2019-2030 5.6.2 Asia Pacific Medicinal Carbon Sales Value by Country (%), 2023 VS 2030 5.7 South America 5.7.1 South America Medicinal Carbon Sales Value, 2019-2030 5.7.2 South America Medicinal Carbon Sales Value by Country (%), 2023 VS 2030 5.8 Middle East & Africa 5.8.1 Middle East & Africa Medicinal Carbon Sales Value, 2019-2030 5.8.2 Middle East & Africa Medicinal Carbon Sales Value by Country (%), 2023 VS 2030 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Medicinal Carbon Sales Value Growth Trends, 2019 VS 2023 VS 2030 6.2 Key Countries/Regions Medicinal Carbon Sales Value 6.2.1 Key Countries/Regions Medicinal Carbon Sales Value, 2019-2030 6.2.2 Key Countries/Regions Medicinal Carbon Sales Volume, 2019-2030 6.3 United States 6.3.1 United States Medicinal Carbon Sales Value, 2019-2030 6.3.2 United States Medicinal Carbon Sales Value by Type (%), 2023 VS 2030 6.3.3 United States Medicinal Carbon Sales Value by Application, 2023 VS 2030 6.4 Europe 6.4.1 Europe Medicinal Carbon Sales Value, 2019-2030 6.4.2 Europe Medicinal Carbon Sales Value by Type (%), 2023 VS 2030 6.4.3 Europe Medicinal Carbon Sales Value by Application, 2023 VS 2030 6.5 China 6.5.1 China Medicinal Carbon Sales Value, 2019-2030 6.5.2 China Medicinal Carbon Sales Value by Type (%), 2023 VS 2030 6.5.3 China Medicinal Carbon Sales Value by Application, 2023 VS 2030 6.6 Japan 6.6.1 Japan Medicinal Carbon Sales Value, 2019-2030 6.6.2 Japan Medicinal Carbon Sales Value by Type (%), 2023 VS 2030 6.6.3 Japan Medicinal Carbon Sales Value by Application, 2023 VS 2030 6.7 South Korea 6.7.1 South Korea Medicinal Carbon Sales Value, 2019-2030 6.7.2 South Korea Medicinal Carbon Sales Value by Type (%), 2023 VS 2030 6.7.3 South Korea Medicinal Carbon Sales Value by Application, 2023 VS 2030 6.8 Southeast Asia 6.8.1 Southeast Asia Medicinal Carbon Sales Value, 2019-2030 6.8.2 Southeast Asia Medicinal Carbon Sales Value by Type (%), 2023 VS 2030 6.8.3 Southeast Asia Medicinal Carbon Sales Value by Application, 2023 VS 2030 6.9 India 6.9.1 India Medicinal Carbon Sales Value, 2019-2030 6.9.2 India Medicinal Carbon Sales Value by Type (%), 2023 VS 2030 6.9.3 India Medicinal Carbon Sales Value by Application, 2023 VS 2030 7 Company Profiles 7.1 NORIT 7.1.1 NORIT Company Information 7.1.2 NORIT Introduction and Business Overview 7.1.3 NORIT Medicinal Carbon Sales, Revenue and Gross Margin (2019-2024) 7.1.4 NORIT Medicinal Carbon Product Offerings 7.1.5 NORIT Recent Development 7.2 EcoFriend Carbon 7.2.1 EcoFriend Carbon Company Information 7.2.2 EcoFriend Carbon Introduction and Business Overview 7.2.3 EcoFriend Carbon Medicinal Carbon Sales, Revenue and Gross Margin (2019-2024) 7.2.4 EcoFriend Carbon Medicinal Carbon Product Offerings 7.2.5 EcoFriend Carbon Recent Development 7.3 Emis Vito 7.3.1 Emis Vito Company Information 7.3.2 Emis Vito Introduction and Business Overview 7.3.3 Emis Vito Medicinal Carbon Sales, Revenue and Gross Margin (2019-2024) 7.3.4 Emis Vito Medicinal Carbon Product Offerings 7.3.5 Emis Vito Recent Development 7.4 Kuraray 7.4.1 Kuraray Company Information 7.4.2 Kuraray Introduction and Business Overview 7.4.3 Kuraray Medicinal Carbon Sales, Revenue and Gross Margin (2019-2024) 7.4.4 Kuraray Medicinal Carbon Product Offerings 7.4.5 Kuraray Recent Development 7.5 Barnebey Cheney 7.5.1 Barnebey Cheney Company Information 7.5.2 Barnebey Cheney Introduction and Business Overview 7.5.3 Barnebey Cheney Medicinal Carbon Sales, Revenue and Gross Margin (2019-2024) 7.5.4 Barnebey Cheney Medicinal Carbon Product Offerings 7.5.5 Barnebey Cheney Recent Development 7.6 Dupont 7.6.1 Dupont Company Information 7.6.2 Dupont Introduction and Business Overview 7.6.3 Dupont Medicinal Carbon Sales, Revenue and Gross Margin (2019-2024) 7.6.4 Dupont Medicinal Carbon Product Offerings 7.6.5 Dupont Recent Development 7.7 Dolder 7.7.1 Dolder Company Information 7.7.2 Dolder Introduction and Business Overview 7.7.3 Dolder Medicinal Carbon Sales, Revenue and Gross Margin (2019-2024) 7.7.4 Dolder Medicinal Carbon Product Offerings 7.7.5 Dolder Recent Development 7.8 Atlas Carbon 7.8.1 Atlas Carbon Company Information 7.8.2 Atlas Carbon Introduction and Business Overview 7.8.3 Atlas Carbon Medicinal Carbon Sales, Revenue and Gross Margin (2019-2024) 7.8.4 Atlas Carbon Medicinal Carbon Product Offerings 7.8.5 Atlas Carbon Recent Development 7.9 Calgon Carbon Corporation 7.9.1 Calgon Carbon Corporation Company Information 7.9.2 Calgon Carbon Corporation Introduction and Business Overview 7.9.3 Calgon Carbon Corporation Medicinal Carbon Sales, Revenue and Gross Margin (2019-2024) 7.9.4 Calgon Carbon Corporation Medicinal Carbon Product Offerings 7.9.5 Calgon Carbon Corporation Recent Development 7.10 Witco Chemical Corporation 7.10.1 Witco Chemical Corporation Company Information 7.10.2 Witco Chemical Corporation Introduction and Business Overview 7.10.3 Witco Chemical Corporation Medicinal Carbon Sales, Revenue and Gross Margin (2019-2024) 7.10.4 Witco Chemical Corporation Medicinal Carbon Product Offerings 7.10.5 Witco Chemical Corporation Recent Development 7.11 Ingevity 7.11.1 Ingevity Company Information 7.11.2 Ingevity Introduction and Business Overview 7.11.3 Ingevity Medicinal Carbon Sales, Revenue and Gross Margin (2019-2024) 7.11.4 Ingevity Medicinal Carbon Product Offerings 7.11.5 Ingevity Recent Development 7.12 Osaka Gas Co.,Ltd. 7.12.1 Osaka Gas Co.,Ltd. Company Information 7.12.2 Osaka Gas Co.,Ltd. Introduction and Business Overview 7.12.3 Osaka Gas Co.,Ltd. Medicinal Carbon Sales, Revenue and Gross Margin (2019-2024) 7.12.4 Osaka Gas Co.,Ltd. Medicinal Carbon Product Offerings 7.12.5 Osaka Gas Co.,Ltd. Recent Development 7.13 Haycarb PLC 7.13.1 Haycarb PLC Company Information 7.13.2 Haycarb PLC Introduction and Business Overview 7.13.3 Haycarb PLC Medicinal Carbon Sales, Revenue and Gross Margin (2019-2024) 7.13.4 Haycarb PLC Medicinal Carbon Product Offerings 7.13.5 Haycarb PLC Recent Development 8 Industry Chain Analysis 8.1 Medicinal Carbon Industrial Chain 8.2 Medicinal Carbon Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Medicinal Carbon Sales Model 8.5.2 Sales Channel 8.5.3 Medicinal Carbon Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(ケミカル)の最新刊レポートQYResearch社の化学・材料分野での最新刊レポート
本レポートと同じKEY WORD()の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/12/23 10:26 157.72 円 164.94 円 201.11 円 |